Tag: contraceptive drugs and devices market share

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Contraceptive Drugs And Devices Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The market for contraceptive drugs and devices has experienced robust expansion over recent years. This market is projected to expand from $26.98 billion in 2025 to $28.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Historically, this expansion can be linked to several factors, including government-spearheaded family planning programs, a heightened understanding of reproductive health, increasing levels of urbanization and education, broader access to oral contraceptives, and public health initiatives promoting birth control.

The contraceptive drugs and devices market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $38.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This projected growth during the forecast period is driven by increased integration of digital health, a rising demand for non-invasive contraceptive methods, the expansion of telehealth-based prescriptions, a growing emphasis on male contraception research, and supportive reproductive health policies. Noteworthy trends for this period include a greater adoption of long-acting reversible contraceptives, increased use of hormonal combination therapies, a burgeoning demand for female-centric contraceptive solutions, the wider availability of over-the-counter contraceptive products, and enhanced acceptance of digital contraceptive platforms.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=81086806&type=smp&name=Contraceptive%20Drugs%20And%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Contraceptive Drugs And Devices Market Demand Drivers: What’s Powering Industry Growth?

The growing count of government efforts regarding reproductive health is anticipated to stimulate the advancement of the contraceptive drugs and devices market in the future. These government initiatives champion reproductive well-being by fostering awareness, providing funding, and ensuring access to relevant services. The increase in government initiatives concerning reproductive health stems from a heightened acknowledgment of the necessity to tackle crucial matters such as maternal health, family planning, and the availability of fundamental healthcare services, all of which are essential for overall societal welfare and development. Government programs for contraceptive drugs and devices are designed to broaden access to economical and effective family planning solutions, enabling individuals to make informed decisions regarding their reproductive health. As an illustration, in November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, confirmed that Australia will commit $56.8 million to a fresh program focused on advancing sexual and reproductive health and rights across Southeast Asia. Hence, the rising volume of government initiatives concerning reproductive health is fueling the expansion of the contraceptive drugs and devices market.

Contraceptive Drugs And Devices Market Segment Landscape: Which Areas Lead Development?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

Contraceptive Drugs And Devices Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading companies within the contraceptive drugs and devices market are engaged in developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand the array of long-acting contraceptive options. A contraceptive vaginal ring is a pliant, hormone-releasing device designed for vaginal insertion to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing, a soft, flexible contraceptive vaginal ring. It is specifically designed for insertion into the vagina, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it offers women a convenient, discreet, and cost-effective monthly birth control choice that removes the necessity for daily dosing while maintaining the identical safety, efficacy, and tolerability profile as the branded version.

Contraceptive Drugs And Devices Market Industry Leaders And Competitive Landscape

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

View The Full Contraceptive Drugs And Devices Market Report:

https://thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Contraceptive Drugs And Devices Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Contraceptive Drugs And Devices Market Value Expansion And Long-Term Growth Outlook

The contraceptive drugs and devices market has experienced robust expansion in recent years. It is anticipated to increase from $26.98 billion in 2025 to $28.9 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.1%. This historic upswing has been driven by government-led family planning initiatives, heightened awareness of reproductive health, rising urbanization and education levels, broader accessibility of oral contraceptives, and public health campaigns focused on birth control.

The contraceptive drugs and devices market is projected to experience robust expansion over the next several years, anticipated to reach $38.08 billion by 2030 at a compound annual growth rate of 7.1%. This forecasted growth is driven by several factors, including the increasing integration of digital health solutions, a rising preference for non-invasive contraceptive options, the broader availability of telehealth-based prescriptions, intensified research into male contraception, and the implementation of supportive reproductive health policies. Key developments expected to shape the sector during this period include a higher adoption rate of long-acting reversible contraceptives, the growing use of hormonal combination therapies, a stronger focus on female-centric contraceptive products, the widening accessibility of over-the-counter contraceptive items, and the expanding acceptance of digital platforms for contraception management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Contraceptive Drugs And Devices Market Expansion Drivers: What Is Shaping Future Growth?

The growing number of government programs focused on reproductive health is anticipated to drive the growth of the contraceptive drugs and devices market in the coming years. These governmental efforts advance reproductive health by providing education, financial support, and improved service access. An increase in such initiatives is observed due to a heightened acknowledgment of the necessity to tackle issues like maternal care, family planning, and the provision of vital health services, all of which are essential for broader societal progress and welfare. Government measures related to contraceptive drugs and devices are designed to enhance the availability of low-cost and effective family planning options, empowering individuals to make well-informed decisions regarding their reproductive health. For example, as reported in November 2024 by the Australian Government Department of Foreign Affairs and Trade, a federal agency in Australia, the country will commit $56.8 million to a new program promoting sexual and reproductive health and rights across Southeast Asia. Consequently, the proliferation of government initiatives on reproductive health is fueling the expansion of the contraceptive drugs and devices market.

Contraceptive Drugs And Devices Market Segment Outlook: Which Categories Are Expanding The Fastest?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

Contraceptive Drugs And Devices Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Key players in the contraceptive drugs and devices market are introducing new products like contraceptive vaginal rings to improve ease of use and broaden the range of long-acting contraception. A contraceptive vaginal ring is a flexible device that releases hormones and is placed in the vagina to stop ovulation and prevent pregnancy. An example is EnilloRing, which was launched by Xiromed LLC, a pharmaceutical company based in the US, in October 2023. This soft and flexible contraceptive ring is inserted into the vagina, releasing a steady combination of etonogestrel, a progestin, and ethinyl estradiol, an estrogen, for three weeks to suppress ovulation. As a generic version that is bioequivalent to NuvaRing, it provides women with a convenient, discreet, and affordable monthly birth control solution that removes the need for a daily pill, while offering the same safety, effectiveness, and tolerance as the branded option.

Contraceptive Drugs And Devices Market Key Companies And Competitive Benchmarking

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Access The Complete Contraceptive Drugs And Devices Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Contraceptive Drugs And Devices Market Largest Region By Revenue And Market Share

North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Contraceptive Drugs And Devices Market Change Between 2026 And 2030?

The contraceptive drugs and devices market has experienced robust growth in recent years. It is anticipated to expand from $26.98 billion in 2025 to $28.9 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.1%. This historical expansion can be linked to government-led family planning initiatives, enhanced awareness of reproductive health, increasing urbanization and education levels, greater accessibility of oral contraceptives, and public health campaigns focused on birth control.

The market for contraceptive drugs and devices is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $38.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This forecasted expansion is primarily driven by factors such as enhanced digital health integration, increasing consumer preference for non-invasive contraception, the broadening scope of telehealth for prescriptions, heightened research into male contraception, and supportive government policies related to reproductive health. Key developments expected during this period involve a greater uptake of long-acting reversible contraceptives, more widespread application of hormonal combination therapies, a growing emphasis on contraceptive options for women, the wider availability of over-the-counter contraceptive items, and increasing comfort with digital platforms for contraception.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

What Key Growth Drivers Are Influencing The Contraceptive Drugs And Devices Market?

An increasing number of government initiatives concerning reproductive health is anticipated to drive the growth of the contraceptive drugs and devices market moving forward. These governmental efforts promote reproductive well-being through heightened awareness, financial provision, and improved access to essential services. The rise in government initiatives related to reproductive health is due to a growing recognition of the importance of addressing issues such as maternal health, family planning, and access to fundamental healthcare services, which are critical for overall societal welfare and development. Government programs for contraceptive drugs and devices aim to enhance the availability of affordable and effective family planning methods, ensuring individuals can make informed choices about their reproductive health. For instance, in November 2024, according to the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, Australia is set to allocate $56.8 million to a new project focused on advancing sexual and reproductive health and rights in Southeast Asia. Consequently, the escalating number of government initiatives regarding reproductive health is fueling the expansion of the contraceptive drugs and devices market.

Which Segment Divisions Form The Structure Of The Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

What Trends Are Influencing The Contraceptive Drugs And Devices Market?

Leading companies in the contraceptive drugs and devices market are developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device placed into the vagina to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced EnilloRing, a soft, flexible, contraceptive vaginal ring designed for vaginal insertion, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it provides women with a convenient, discreet, and cost-effective monthly birth control option that removes the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.

Which Companies Are Influencing The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Access The Complete Contraceptive Drugs And Devices Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Which Region Contributes The Most To The Contraceptive Drugs And Devices Market?

North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Contraceptive Drugs And Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Contraceptive Drugs And Devices Market During The Forecast Period?

The contraceptive drugs and devices market has shown robust growth recently. This market is anticipated to expand from $26.98 billion in 2025 to reach $28.9 billion in 2026, growing at a compound annual rate (CAGR) of 7.1%. Historically, this expansion has been driven by factors such as government-backed family planning programs, heightened understanding of reproductive health, increasing urbanization and improved education, greater access to oral contraceptives, and public health initiatives promoting birth control.

The contraceptive drugs and devices market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $38.08 billion, exhibiting a compound annual growth rate (CAGR) of 7.1%. This projected growth is driven by several factors, including enhanced digital health integration, an increasing preference for non-invasive contraceptive options, the spread of telehealth-based prescription services, intensified research into male contraception, and supportive reproductive health policies. Key trends expected during this period involve the greater uptake of long-acting reversible contraceptives, an uptick in the application of hormonal combination therapies, a heightened call for female-focused contraceptive innovations, the wider availability of over-the-counter contraceptive items, and increasing embrace of digital contraceptive platforms.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

Which Primary Drivers Are Impacting The Contraceptive Drugs And Devices Market Growth?

An increasing volume of government programs focused on reproductive health is anticipated to fuel the expansion of the contraceptive drugs and devices market in the future. These initiatives support reproductive well-being by fostering awareness, providing financial backing, and facilitating access to essential services. The growth in government efforts concerning reproductive health stems from an escalating understanding of the necessity to tackle concerns like maternal health, family planning, and access to vital healthcare, all fundamental for societal progress and welfare. Specific government programs for contraceptive drugs and devices seek to broaden availability of cost-effective and efficient family planning options, empowering individuals to make educated decisions regarding their reproductive health. As an illustration, in November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, confirmed that Australia plans to commit $56.8 million towards a new endeavor to advance sexual and reproductive health and rights across Southeast Asia. Consequently, the growing count of government initiatives centered on reproductive health is significantly boosting the enlargement of the contraceptive drugs and devices market.

Which Segments Define The Contraceptive Drugs And Devices Market Segment Structure?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

What Trends Are Transforming The Contraceptive Drugs And Devices Market?

Leading companies in the contraceptive drugs and devices market are innovating products, such as contraceptive vaginal rings, to improve user convenience and broaden long-acting birth control choices. A contraceptive vaginal ring is a pliable, hormone-emitting device positioned in the vagina to deter pregnancy by hindering ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, introduced EnilloRing, a soft, flexible contraceptive vaginal ring specifically designed for vaginal insertion, where it consistently releases a combination of etonogestrel (a progestin) and ethinyl estradiol (a estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it presents women with an accessible, discreet, and cost-effective monthly birth control alternative that eliminates the necessity for daily dosing while maintaining the identical safety, efficacy, and tolerability characteristics of the branded version.

Who Are The Established Players Within The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Get The Full Contraceptive Drugs And Devices Market Report:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Which Region Accounts For The Largest Portion Of The Contraceptive Drugs And Devices Market?

North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Contraceptive Drugs And Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Contraceptive Drugs And Devices Market By 2030 Starting From Its 2026 Size?

The contraceptive drugs and devices market has shown significant growth in recent years. This market is set to increase from $26.98 billion in 2025 to $28.9 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. The expansion observed in the past can be credited to various elements, such as government-led family planning programs, increased understanding of reproductive health, rising urbanization and educational levels, wider availability of oral contraceptives, and public health campaigns advocating for birth control.

The contraceptive drugs and devices market size is anticipated to experience robust growth in the upcoming years, projected to reach $38.08 billion by 2030, at a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period can be attributed to factors such as increased digital health integration, a rising preference for non-invasive contraceptive methods, the proliferation of telehealth-based prescriptions, a heightened focus on research into male contraception, and supportive reproductive health policies. Noteworthy trends expected in this period include the increased adoption of long-acting reversible contraceptives, a growing use of hormonal combination therapies, a surge in demand for female-centric contraceptive solutions, the expansion of over-the-counter contraceptive products, and the increasing acceptance of digital contraceptive platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

Which Market Drivers Are Supporting The Expansion Of The Contraceptive Drugs And Devices Market?

An increasing volume of government programs concerning reproductive health is anticipated to fuel the expansion of the contraceptive drugs and devices market moving ahead. These governmental efforts advance reproductive well-being by fostering public understanding, providing financial support, and facilitating entry to relevant services. The proliferation of government programs focused on reproductive health stems from an increasing acknowledgment of the necessity to tackle matters like maternal wellness, family planning, and availability of vital healthcare provisions, all indispensable for collective societal health and advancement. The objectives of government projects for contraceptive drugs and devices include enhancing access to economical and efficient family planning options, thereby enabling individuals to make educated decisions regarding their reproductive health. As an illustration, in November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, reported that Australia plans to commit $56.8 million to a fresh endeavor designed to advance sexual and reproductive health and rights across Southeast Asia. Consequently, the increasing frequency of governmental actions related to reproductive health is stimulating the growth of the contraceptive drugs and devices market.

Which Segment Categories Define The Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

What Major Market Trends Are Driving Changes In The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing, a soft, flexible, contraceptive vaginal ring designed to be inserted into the vagina, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it offers women a convenient, discreet, and cost-effective monthly birth control option that eliminates the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.

Who Are The Top Companies Competing In The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Read the full contraceptive drugs and devices market report here:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

How Is The Contraceptive Drugs And Devices Market Distributed Across Key Geographic Regions?

North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Contraceptive Drugs And Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptive drugs and devices market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Contraceptive Drugs And Devices Market reach by 2030 starting from 2026 levels?

The contraceptive drugs and devices market has experienced robust expansion in recent years. Its value is projected to increase from $26.98 billion in 2025 to $28.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market is attributable to government-led family planning initiatives, heightened awareness of reproductive health, rising urbanization and education levels, wider availability of oral contraceptives, and public health campaigns for birth control.

The contraceptive drugs and devices market is projected to experience substantial expansion in the coming years. This market is forecasted to reach $38.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. The anticipated growth during this period is driven by factors such as enhanced digital health integration, a surge in demand for non-invasive contraceptive options, the broadening availability of telehealth prescriptions, an increased emphasis on male contraception research, and favorable reproductive health policies. Key trends for the projected timeframe encompass a growing uptake of long-acting reversible contraceptives, an uptick in the application of hormonal combination therapies, heightened demand for contraceptive solutions designed for women, the expansion of over-the-counter contraceptive offerings, and wider acceptance of digital platforms for contraception.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

Which Drivers Are Influencing Long-Term Growth In The Contraceptive Drugs And Devices Market?

The increasing number of government programs focused on reproductive health is projected to drive the growth of the contraceptive drugs and devices market in the future. Government initiatives actively promote reproductive well-being through public awareness efforts, financial provisions, and enhanced access to relevant services. These initiatives are expanding due to a growing recognition of the imperative to address critical concerns such as maternal health, family planning, and access to essential healthcare, which are fundamental for overall societal welfare and advancement. Furthermore, government initiatives for contraceptive drugs and devices are designed to increase the availability of affordable and effective family planning methods, enabling individuals to make educated choices regarding their reproductive health. An illustration of this is Australia’s plan, announced in November 2024 by the Australian Government Department of Foreign Affairs and Trade, to allocate $56.8 million towards a new project aimed at fostering sexual and reproductive health and rights across Southeast Asia. Therefore, the rising prevalence of government initiatives concerning reproductive health is a key factor expanding the contraceptive drugs and devices market.

Which Segments Are Driving Activity In The Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

What Long-Term Trends Are Expected To Shape The Future Of The Contraceptive Drugs And Devices Market?

Leading companies active in the contraceptive drugs and devices market are developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing, a soft, flexible, contraceptive vaginal ring designed to be inserted into the vagina, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it offers women a convenient, discreet, and cost-effective monthly birth control option that eliminates the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.

Which Major Firms Are Strengthening Their Position In The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Contraceptive Drugs And Devices Market?

North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Contraceptive Drugs And Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptive drugs and devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Contraceptive Drugs And Devices Market In The Period 2029-2034?

The market for contraceptive drugs and devices has experienced significant expansion recently. Projections indicate its size will increase from $25.3 billion in 2024 to reach $26.98 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors such as demographic increase, heightened public knowledge of family planning, governmental support and financial backing, a growing female workforce, and innovations in contraceptive methods.

The contraceptive drugs and devices market is projected to experience substantial expansion in the coming years. This market is predicted to reach $35.55 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this anticipated growth include an increasing demand for long-acting reversible contraceptives, a heightened emphasis on women’s reproductive health, the rising occurrence of sexually transmitted infections, broader accessibility via e-commerce and telehealth platforms, along with favorable healthcare policies and comprehensive insurance coverage. Key trends expected during this period encompass smart contraceptive devices featuring digital tracking capabilities, biodegradable implants and patches, breakthroughs in hormone-free contraception, artificial intelligence-powered fertility monitoring applications, and the use of 3D printing for personalized contraceptive devices.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

What Strategic Drivers Are Accelerating The Contraceptive Drugs And Devices Market Expansion?

An increasing number of government programs focused on reproductive health is projected to drive the expansion of the contraceptive drugs and devices market moving ahead. These governmental efforts advance reproductive well-being by raising awareness, providing financial support, and ensuring availability of services. The expansion of government programs concerning reproductive health stems from a growing acknowledgment of the necessity to tackle matters like maternal health, family planning, and access to vital healthcare provisions, all of which are fundamental for comprehensive societal prosperity and progress. Specific government endeavors for contraceptive drugs and devices seek to enhance the availability of economical and efficient family planning options, thereby enabling individuals to make educated decisions regarding their reproductive health. As an illustration, in November 2024, as reported by the Australian Government Department of Foreign Affairs and Trade, an Australia-based governmental body, Australia plans to commit $56.8 million towards a new project designed to advance sexual and reproductive health and rights across Southeast Asia. Consequently, the growing volume of government initiatives regarding reproductive health is fueling the growth of the contraceptive drugs and devices market.

What Is The Detailed Segment Distribution Of The Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

How Are Global Trends Impacting The Development Of The Contraceptive Drugs And Devices Market?

Leading companies active in the contraceptive drugs and devices market are innovating products like contraceptive vaginal rings to improve user convenience and increase long-acting contraceptive alternatives. A contraceptive vaginal ring is a pliable, hormone-emitting device positioned in the vagina to prevent pregnancy through the suppression of ovulation. For example, in October 2023, Xiromed LLC, a US-based pharmaceutical firm, introduced EnilloRing, a gentle, flexible contraceptive vaginal ring crafted for vaginal insertion. It continuously releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to inhibit ovulation. As a bioequivalent generic to NuvaRing, it provides women with a convenient, private, and budget-friendly monthly birth control solution that eliminates daily dosing while retaining the same safety, efficacy, and tolerability profile as the branded version.

Who Are The Major Stakeholders Operating In The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Contraceptive Drugs And Devices Market?

North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2025, By The Business Research Company

Cervical Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Kidney Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Contraceptive Drugs And Devices Industry Compare Between 2025 And 2029?

The contraceptive drugs and devices market size has experienced robust expansion in recent years. This market is projected to expand from $25.3 billion in 2024 to $26.98 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors such as population growth, an increased understanding of family planning, various government programs and financial support, a rise in the female workforce, and innovations in contraceptive technologies.

The market for contraceptive drugs and devices is projected to experience robust expansion over the coming years. This market is anticipated to reach $35.55 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth include a rising demand for long-acting reversible contraceptives, a heightened emphasis on women’s reproductive health, the increasing incidence of sexually transmitted infections, wider availability via e-commerce and telehealth platforms, along with favorable healthcare policies and comprehensive insurance coverage. Key trends expected during this period encompass smart contraceptive devices featuring digital tracking capabilities, biodegradable implants and patches, novel hormone-free contraceptive solutions, artificial intelligence-powered fertility monitoring applications, and the use of 3D printing for personalized contraceptive devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

Which Industry Drivers Are Expected To Accelerate The Contraceptive Drugs And Devices Market From 2025 To 2029?

The increasing volume of government initiatives concerning reproductive health is anticipated to stimulate the expansion of the contraceptive drugs and devices market moving forward. These initiatives advance reproductive health through public awareness campaigns, financial support, and improved access to services. The growth in government initiatives regarding reproductive health stems from a heightened awareness of the necessity to tackle concerns like maternal health, family planning, and accessibility to vital healthcare services, all of which are fundamental for societal welfare and progress. Initiatives focused on contraceptive drugs and devices specifically aim to broaden access to affordable and efficacious family planning methods, enabling individuals to make educated decisions about their reproductive health. For example, in November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, stated that Australia plans to commit $56.8 million towards a new program designed to champion sexual and reproductive health and rights in Southeast Asia. Consequently, the rising number of government initiatives about reproductive health is propelling the growth of the contraceptive drugs and devices market.

What Are The Major Segment Types Covered In The Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

Which Key Trends Are Expected To Influence The Contraceptive Drugs And Devices Market In The Coming Years?

Leading companies within the contraceptive drugs and devices market are innovating products like contraceptive vaginal rings to boost user convenience and expand long-acting contraceptive choices. A contraceptive vaginal ring is a pliable, hormone-releasing device placed in the vagina to prevent pregnancy by suppressing ovulation. For example, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing. This soft, flexible contraceptive vaginal ring is designed for vaginal insertion, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to inhibit ovulation. As a bioequivalent generic to NuvaRing, it presents women with a convenient, discreet, and cost-effective monthly birth control method, removing the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.

Which Global Market Leaders Are Shaping The Future Of The Contraceptive Drugs And Devices Sector?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

How Does The Contraceptive Drugs And Devices Market Perform Across Key Geographic Regions?

North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Contraceptive Drugs And Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2025, By The Business Research Company

Cervical Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Kidney Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Present And Forecasted Size Of The Contraceptive Drugs And Devices Market?

In the past few years, the contraceptive drugs and devices market has experienced robust growth. Projected to see a rise from $25.3 billion in 2024 to $26.98 billion in 2025, the market is set to exhibit a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this strong growth trajectory during the historical period include population expansion, increasing awareness about family planning, government-led initiatives and funding, a rise in women joining the workforce, and technological advancements in contraceptive methods.

The market for contraceptive drugs and devices is anticipated to experience substantial growth in the coming years, reaching a valuation of $35.55 billion in 2029 with a compound annual growth rate (CAGR) of 7.1%. This predicted increase during the forecast period is primarily due to factors such as the rising demand for long-acting reversible contraceptives, an increased emphasis on women’s reproductive health, the growing occurrence of sexually transmitted infections, broader access facilitated by e-commerce and telehealth, favorable healthcare policies, and insurance coverage. Key trends during the forecast horizon include smart contraceptive devices integrating digital tracking, biodegradable implants and patches, innovations in hormone-free contraceptives, AI-powered fertility tracking applications, and 3D printing of tailored contraceptive devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

What Market Forces Are Contributing To The Growth Of The Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market is expected to see significant growth due to the increasing number of government initiatives centered on reproductive health. These initiatives largely focus on increasing awareness, making resources accessible, and allocating funds towards reproductive health services. The growth of such initiatives stems from a growing recognition of the necessity to deal with aspects such as maternal health, family planning, and reaching out essential health care services that are incredibly important for societal well-being and progress. The focus of these government initiatives for contraceptive drugs and devices is to amplify the accessibility of affordable, effective family planning methods, ensuring people are well-informed about their reproductive health decisions. For instance, in November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australian government agency, plans to commit $56.8 million towards a new initiative that aims to promote sexual and reproductive health and rights in Southeast Asia. Hence, the growth of the contraceptive drugs and devices market is being largely driven by these increasing numbers of government initiatives focusing on reproductive health.

What Segmentation Insights Are Provided In The Contraceptive Drugs And Devices Market Research?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

Which Notable Trends Are Transforming The Contraceptive Drugs And Devices Market Outlook?

Key players in the contraceptive drugs and devices market are focusing on the development of advanced products such as contraceptive vaginal rings to improve accessibility and broaden the range of long-term contraceptive methods. A contraceptive vaginal ring, a flexible device that releases hormones, is applied into the vagina to avoid pregnancy by suppressing ovulation. For example, in October 2023, the American pharmaceutical firm, Xiromed LLC, introduced EnilloRing, a supple, comfortable contraceptive vaginal ring designed to be positioned in the vagina. It continuously dispenses a mix of etonogestrel (a type of progestin) and ethinyl estradiol (a form of estrogen) over a three-week period to stop ovulation. As it is a bioequivalent generic to NuvaRing, it presents women with a practical, unobtrusive, and economical monthly contraception method that eliminates the requirement for daily intake while preserving the same safety, effectiveness, and tolerability as the original product.

Who Are The Major Stakeholders Operating In The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Contraceptive Drugs And Devices Market?

North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model